Last reviewed · How we verify
Frio Oral Rinse
At a glance
| Generic name | Frio Oral Rinse |
|---|---|
| Sponsor | Biomedical Development Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Exploratory Study of Iocide Oral Rinse in a Diabetic Population (PHASE1)
- Treatment and/or Prevention of Urinary Tract Infections (PHASE1)
- Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
- Pilot Efficacy Study to Treat Gingivitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Frio Oral Rinse CI brief — competitive landscape report
- Frio Oral Rinse updates RSS · CI watch RSS
- Biomedical Development Corporation portfolio CI